International variation in chemotherapy use in cancer - Authors' reply.

Barclay, Matthew E; McPhail, Sean; Johnson, Shane A; Swann, Ruth; Lyratzopoulos, Georgios

Barclay, Matthew E; McPhail, Sean; Johnson, Shane A; Swann, Ruth; Lyratzopoulos, Georgios.

Affiliation

Barclay ME; Epidemiology of Cancer Healthcare & Outcomes, Department of Behavioural Science & Health, Institute of Epidemiology & Health Care, University College London, London WC1E 7HB, UK.
McPhail S; National Disease Registration Service, NHS England, Leeds, UK.
Johnson SA; Cancer Intelligence, Cancer Research UK, London, UK.
Swann R; National Disease Registration Service, NHS England, Leeds, UK; Cancer Intelligence, Cancer Research UK, London, UK.
Lyratzopoulos G; Epidemiology of Cancer Healthcare & Outcomes, Department of Behavioural Science & Health, Institute of Epidemiology & Health Care, University College London, London WC1E 7HB, UK; National Disease Registration Service, NHS England, Leeds, UK. Electronic address: y.lyratzopoulos@ucl.ac.uk.

Lancet Oncol ; 25(6): e232, 2024 Jun.

Article in En | MEDLINE | ID: mdl-38821093

Subject(s)

Neoplasms; Humans; Neoplasms/drug therapy; Antineoplastic Agents/therapeutic use; Antineoplastic Agents/adverse effects; Practice Patterns, Physicians'/standards

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms Limits: Humans Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2024 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google